Maven Securities LTD - EVAXION BIOTECH A S ownership

EVAXION BIOTECH A S's ticker is EVAX and the CUSIP is 29970R105. A total of 8 filers reported holding EVAXION BIOTECH A S in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Maven Securities LTD ownership history of EVAXION BIOTECH A S
ValueSharesWeighting
Q3 2021$2,148,000
+22.0%
222,806
-5.4%
0.07%
-2.8%
Q2 2021$1,760,000
+38.8%
235,606
+2.2%
0.07%
+24.6%
Q1 2021$1,268,000230,6060.06%
Other shareholders
EVAXION BIOTECH A S shareholders Q3 2021
NameSharesValueWeighting ↓
Ground Swell Capital, LLC 18,071$32,5280.14%
Telemetry Investments, L.L.C. 37,500$680.11%
Beacon Capital Management, LLC 6,881$12,2140.00%
PURA VIDA INVESTMENTS, LLC 16,842$29,8950.00%
MORGAN STANLEY 3,696$6,5600.00%
Citadel Advisors 13,000$23,4000.00%
Citadel Advisors 500$9000.00%
Citadel Advisors 1,485$2,6730.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 41,600$74,8800.00%
UBS Group AG 5,081$9,0440.00%
View complete list of EVAXION BIOTECH A S shareholders